Timing of Antiretroviral Treatment, Immunovirologic Status and TB Risk: Implications for Test and Treat

BACKGROUND: TB risk and mortality increase in the six months following HAART initiation. This short-term risk may be a consequence of HAART initiation and immune reconstitution. Alternatively, it may be due to confounding by low CD4+ counts and high HIV viral loads (VL). We assessed TB risk before a...

Full description

Saved in:
Bibliographic Details
Published in:J Acquir Immune Defic Syndr
Main Authors: PETTIT, April C., MENDES, Adell, JENKINS, Cathy, NAPRAVNIK, Sonia, FREEMAN, Aimee, SHEPHERD, Bryan E., DOWDY, David, GILL, John, RACHLIS, Anita, MOORE, Richard, STERLING, Timothy R.
Format: Artigo
Language:Inglês
Published: 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4942351/
https://ncbi.nlm.nih.gov/pubmed/27049511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000001018
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items